sertraline has been researched along with Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Brener, I; Gil-Ad, I; Hornfeld, SH; Taler, M; Weizman, A | 1 |
| Pu, B; Sun, B; Wang, C; Wang, N | 1 |
| Duarte, D; Vale, N | 1 |
| Mahzoni, H; Moghaddas, A; Momenzadeh, M; Naghsh, E; Sharifi, M | 1 |
| Li, YH; Lian, JL; Sun, X; Wang, YJ; Wu, XM | 1 |
| Dai, S; Everley, RA; Fan, F; Fu, S; Gygi, SP; Hu, J; Li, Y; Liu, B; Liu, J; Ning, X; Qiu, X; Sun, H; Sun, Y; Xu, H; Ye, W; Zhang, C; Zhang, H; Zhang, J; Zhou, C | 1 |
| Arnold, S; Durbin, EB; Kolesar, J; Miller, R; Nichols, D; Weiss, HL; Wu, J | 1 |
| Dai, ZY; Li, DQ; Li, XJ; Yang, WF; Zhen, JP; Zhu, BY | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Garcia, CM; Mumby, PB; Stiff, PJ; Thilges, S | 1 |
| Abdi, EA; Beale, PJ; Carter, C; Dhillon, H; Glasgow, A; Goldstein, D; Heritier, S; Hickie, IB; Jefford, M; Nowak, AK; O'Connell, R; Simes, RJ; Stockler, MR; Turner, J; Wilcken, NR; Wyld, D | 1 |
| Fisch, M | 1 |
| Caldera, P; Siri, I; Torta, R | 1 |
1 review(s) available for sertraline and Neoplasms
| Article | Year |
|---|---|
Antidepressant Drug Sertraline against Human Cancer Cells.
Topics: AMP-Activated Protein Kinases; Antidepressive Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Male; Neoplasms; Oxygen; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sertraline; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2022 |
5 trial(s) available for sertraline and Neoplasms
| Article | Year |
|---|---|
[Effect of
Topics: Acupuncture Points; Acupuncture Therapy; Depression; Humans; Interleukin-2; Neoplasms; Sertraline; Treatment Outcome | 2021 |
Effects of sertraline on executive function and quality of life in patients with advanced cancer.
Topics: Aged; Anxiety; Depression; Executive Function; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Quality of Life; Regression Analysis; Sertraline | 2014 |
Comparison of early quality of life outcomes in autologous and allogeneic transplant patients.
Topics: Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sertraline; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2012 |
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Survival Rate; Treatment Outcome | 2007 |
Sertraline effectiveness and safety in depressed oncological patients.
Topics: Adult; Aged; Antidepressive Agents; Antineoplastic Agents; Anxiety; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Severity of Illness Index; Time Factors | 2008 |
7 other study(ies) available for sertraline and Neoplasms
| Article | Year |
|---|---|
Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level.
Topics: Animals; Anxiety; Cell Proliferation; Citalopram; Mice; Neoplasms; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Clinical observation on the benefits of antidepressant intervention in advanced cancer patients.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Humans; Neoplasms; Sertraline | 2022 |
Potential Drug Interactions in Terminally-Ill Cancer Patients, a Report from the Middle East.
Topics: Cross-Sectional Studies; Drug Interactions; Humans; Middle East; Neoplasms; Oxycodone; Sertraline | 2023 |
Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics.
Topics: Apoptosis; DNA Breaks, Double-Stranded; HeLa Cells; Humans; MCF-7 Cells; Neoplasm Proteins; Neoplasms; Protein Biosynthesis; Proteomics; Recombinational DNA Repair; Sertraline; Tumor Protein, Translationally-Controlled 1 | 2017 |
Pharmacogenomic potential in advanced cancer patients.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Capecitabine; Drug Prescriptions; Female; Humans; Male; Middle Aged; Neoplasms; Ondansetron; Pharmacogenomic Testing; Pharmacogenomic Variants; Precision Medicine; Prospective Studies; Retrospective Studies; Sertraline | 2019 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
Use of antidepressants for depression in patients with advanced cancer.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Neoplasms; Quality of Life; Sertraline; Survival Rate | 2007 |